Asymptomatic Aortic Stenosis and Exercise Test

Slides:



Advertisements
Similar presentations
Underwriting Impact of New Advances in Valvular Heart Disease NEHOUA 2012 Michael Clark, FACC, FLMI, FBIM Chief Medical Director Swiss Re.
Advertisements

Timing and indications of surgery in stenotic and regurgitant valvular lesions Dr.Deepak Raju.
New Developments in the Management of Aortic and Mitral Valve Disorders New Developments in the Management of Aortic and Mitral Valve Disorders Patricia.
Natural history of Aortic stenosis
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Regurgitation.
Evaluation and Management of Asymptomatic Aortic Stenosis. Augusto Pichard, M.D. Director Innovation and Structural Heart Disease, Vice Chair, Medstar.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
Update on Indications for Cardiac Resynchronization Therapy Maria Rosa Costanzo, M.D., F.A.C.C., F.A.H.A. Medical Director, Midwest Heart Specialists-Advocate.
© Continuing Medical Implementation …...bridging the care gap Valvular Heart Disease Aortic Stenosis.
Current Treatment and Future Trends Anthony J. Palazzo, M.D.F.A.C.S.
UNIVERSITY OF SARAJEVO University Clinical Center
Percutaneous mitral valve repair using the MitraClip® device (e-valve)
ACC 2015 Michael J Reardon, MD, FACC On Behalf of the CoreValve US Investigators A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic.
Guidelines for the Management of Patients With Aortic Valve Disease Dr sajeer K T Senior Resident, Dept. of Cardiology, MCH, Calicut.
Common Clinical Scenarios *Younger people *Younger people _Functional murmur vs _Functional murmur vs _ MVP vs _ MVP vs _ AS _ AS *Older people _Aortic.
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
Utilizing Science & Technology and Innovation for Development Transcatheter Therapies For Congenital & Structural Heart Disease Marriott Hotel- Amman,
Locally Agreed Guidelines May Reduce Inappropriate Preoperative Echocardiography Requests Dr Sheila Carey Anaesthetic SpR Northern Deanery.
Balloon Aortic Valvuloplasty AATS Sept Peter C. Block M.D. Andreas Gruentzig Cardiovascular Center Emory University.
Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthesis David H. Adams et al (U.S. CoreValve Clinical Investigators) Journal Club November.
Disclosure Statement of Financial Interest
Ryan Hampton OMS IV January  Considerations Is MR severe? Is patient symptomatic? Is patient a good candidate? What is Left Ventricular function?
Tri-leaflet Aortic Valve. Aortic Stenosis Nishimura, RA et al AHA/ACC Valvular Heart Disease Guideline.
Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Mahmoud ABU-ABEELEH Associate Professor Department of Surgery Division of Cardiothoracic Surgery School of Medicine University Of Jordan Adult Cardiac.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Asymptomatic mitral regurgitation When should you operate? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester.
*Aortic Stenosis is the narrowing of the aortic valve orifice or opening *Read pages 26 – 35 in The Echocardiographer’s Pocket Reference; Read pages 259.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
Echo conference R4 우종신 R4 우종신. Case 1 한 O 태 () Evaluation of severity Planimetry of mitral orifice Planimetry of mitral orifice –only direct measurement.
Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Emerging Role of Exercise Testing and Stress.
The Place of Closed Mitral Valvotomy Procedure in Facility Deprived Countries in the Modern PTMC/PMBV Era: 20 Years Experience at SMS Hospital, Jaipur,
Date of download: 7/7/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for the management of patients.
Validation of cardiac cases. Definition cardiac case/ event Validation process –Data extraction form –Flowcharts Introduction.
Flow-Gradient Patterns in Severe Aortic Stenosis With Preserved Ejection Fraction Clinical Characteristics and Predictors of Survival Mackram F. Eleid,
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Greater New York Geriatric Cardiology Consortium: Valve Disease in Older Adults Allan Schwartz, MD Columbia University Medical Center New York Presbyterian.
© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.
Systematic Review and Meta-Analysis on Management Strategies for Asymptomatic Severe Aortic Stenosis Philippe Généreux, MD Associate Professor of Medicine,
Late breaking news in heart valve disease
David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators
Management of mitral regurgitation. See legend for Fig
Mitral Regurgitation: Epidemiology, Pathophysiology and When to Repair
University of Pennsylvania Philadelphia
AORTIC STENOSIS.
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Early Recovery of Left Ventricular Systolic Function After CoreValve Transcatheter Aortic Valve Replacement Harold L. Dauerman, MD; Michael J. Reardon,
Management strategy for patients with aortic stenosis
Dr M B Connellan Stellenbosch University
Timing of Intervention in Mitral Stenosis
Balloon-Expandable Transcatheter Valve System : OUS Data
Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.
Circ Cardiovasc Imaging
Aortic regurgitation.
by Mario Gössl, Garvan C. Kane, William Mauermann, and David R. Holmes
Cardiovacular Research Technologies
Patrizio Lancellotti et al. JIMG 2016;9:
Johannes Steiner et al. JACC 2017;70:
Johannes Steiner et al. JACC 2017;70:
Figure 2 A patient with aortic stenosis and mitral regurgitation
Ανεπάρκεια Μιτροειδούς : Σταυρόλεξο για δυνατούς λύτες Ποσοτικοποίηση με Ηχωκαρδιογράφημα και ο ρόλος των δοκιμασιών φόρτισης Μαρία Μπόνου Διευθύντρια,
Johannes Steiner et al. JACC 2017;70:
Slides courtesy of Dr. Randall Harada
Rick A. Nishimura et al. JACC 2014;63:e57-e185
Rick A. Nishimura et al. JACC 2017;70:
Patient selection process in the present study.
David H. Harpole, MD, Stanley A. Gall, MD, Walter G. Wolfe, MD, J
A. Procopi, N. Procopi, JP Collet, O. Barthelemy, P. Leprince, R
Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.
Presentation transcript:

Asymptomatic Aortic Stenosis and Exercise Test

Euro Heart Survey on Valvular Heart Disease1 « The use of stress testing was low Essentially aimed at identifying coronary artery disease which it does poorly in the setting of valve disease Too seldom used in asymptomatic patients with valve disease This is particularly true for Aortic Stenosis despite the fact that the performance of the test is strongly advocated » Iung et al.ESC Survey on Valvular Heart Disease. Eur Heart J 2003; 24 : 1231-43

Exercise tests performed AS AR MS MR ET 6.7% 12.2% 7.4% 11.3% AS : 5.7% of asymptomatic patients : under-utilisation 3.2% of NYHA3 et 4 patients : ????? (1) Iung et al.ESC survey on valvular heart disease. Eur Heart J 2003; 24 : 1231-43

Comparison surgical indication/ guidelines2 20,7 % « overused » of intervention (2) Iung et al. Recommendations on the management of the asymptomatic patients with valvular heart disease. Eur Heart J 2002; 23 : 1253-66

How to Avoid Sudden Death in Asymptomatic Aortic Stenosis ? Post operative valve Sudden death surgical mortality relatedcomplication <1% per year (0,4%) 1% (5% after 75 years) 1-2 % per year

Mortality after Aortic Valve Replacement Rahimtoola. Circulation 2000; IV.24-33

But dont operate too late … Valve replacement No surgery (Symptomatic Aortic Stenosis) Scwartz E. Circulation 1982; 66 : 1105-10

Exercise test indications in AS Symptomatic patients : none Reduced Ejection Fraction : none Reduced EF in asymptomatic patients : ~ does not exist Reduced EF in symptomatic patients Surgical indication if mild EF reduction Surgical indication if contractile reserve in low output patients1 (Mean gdt < 30 mm Hg) (1)Monin . Circulation 2003; 108 : 319-324

Exercise test indications in AS(2) Identifying coronary heart disease : none Asymptomatic patients : Strongly recommended1,2 Gibbons ACC/AHA guideline update for exercise testing. Circulation 2002; 106 :1883-92 (2) Iung et al. Recommendations on the management of the asymptomatic patients with valvular heart disease. Eur Heart J 2002; 23 : 1253-66

First study : Feasibility : OTTO 1997 123 asymptomatic patients Followed 2.5 + 1.4 years End points : death or AVR Circulation 1997; 95 : 2262-70

Initial Values End point – (n = 67) End point + (n = 56) P 3.3 + 0.5 Peak Ao jet velocity 3.3 + 0.5 3.9 + 0.5 <0.001 Mean Ao gdt 25 ± 8 36 ± 12 Valve Area 1.53 ± 0.53 1.11 ± 0.34 Impossibility to perform ET 40 % 70 % =0.007 Exercise SBP change 29 ± 20 15 ± 17 Exercise Valve Area change 0.27 ± 0.36 0.05 ± 0.26

Multivariate Analysis Aortic jet velocity at baseline (p < 0.0001) Rate of change over time in jet velocity (p < 0.0001) Baseline functional status score (p = 0.002) Standardized questionnaire Validity in asymptomatic patients ?

Confirmation : Amato1 Selection : out of 853 diagnosed as having aortic valve stenosis : Inclusion if AS < 1 cm2 Asymptomatic Absence of coronary artery disease Exercise test interpretable Absence of LBB (1) Amato MC; Heart 2001; 86 : 381-86

Methods Exercise Test positivity criteria : ST > 2 mm (1mm in men, 2 mm in women, 3 mm for upsloping ST) AS symptoms Complex Ventricular Arrythmia SBP rise < 20 mm Hg End point : death + symptoms

Results Patients Positive exercise test : n = 44 (66%) 49.7 + 14.9 years; men 66% Aortic Valve Area : 0.61 + 0.17 cm2 Positive exercise test : n = 44 (66%) Follow up : 14.8 + 12 months

Valvular area Positive ET

Events : death or symptoms ET positive Symptom free survival : 19 % 4 sudden death (6%) ET negative Symptom free survival : 85 % (RR = 7.43 by multivariate analysis). Zero death Conclusion : Aortic valve replacement can be postponed in asymptomatic patients with negative ET Heart 2001; 86 : 381-6

Other studies Alborino1 Lancellotti2 N = 30 N = 63 Exercise echocardiography Alborino. J Heart Valve Dis 2002; 11 : 204-209 Lancellotti . AHA 2004; abstr n° 3279

Positivity criteria of exercise in ECG in patients with aortic stenosis1 Symptoms : Angina, dyspnea, near syncope Rise in SBP < 20 mmhg (or fall) Exercise tolerance < 80% of the normal target Down-sloping ST > 2mm Complex Ventricular arrythmia VT, more than 4 PVC in a row (1) Iung B et al. Recommendations on the management of the asymptomatic patients With valvular heart disease. Eur Heart J 2002; 23 : 1253-66

Recommendations for Aortic Valve Replacement in Asymptomatic Aortic Stenosis (<1cm2 ou 0.6 cm2/m2) Abnormal ET (IIa) LVEF < 50 % (IIa) LV Hypertrophy > 15 mm (IIb) Valve Area < 0.6 cm2 (IIb) VT (IIb) Prevention of sudden death in asymptomatic patients with none of the five findings above (III) Bonow R et al.ACC/AHA Guidelines for the management of patients with valvular heart disease. JACC 1998; 32(5) : 1486-1588

Aortic Stenosis < 1 cm2 Symptoms And normal or subnormal LVEF Low output Asymptomatic Dobutamine Echo Exercise Test AVR

Severe Aortic stenosis (<1 cm2 or 0.6 cm2/ m2) without symptoms Echocardiography Exercise test BNP ? Exercise Echocardiography ? Positive Negative : close monitoring Aortic Valve Replacement -Peak jet velocity > 4m/s and Progression of PV > 0.3m/s/year and rather severe calcifications -Ventricular arrythmia -> 15 mm Wall thickness